{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/60492-0075#drug","name":"BAT","alternateName":"Botulism Antitoxin Heptavalent","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"60492-0075"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA125462"}],"activeIngredient":"EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2","administrationRoute":["INTRAVENOUS"],"dosageForm":"LIQUID","manufacturer":{"@type":"Organization","name":"Emergent BioSolutions Canada Inc"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"PLASMA DERIVATIVE","sameAs":["https://api.morvs.ai/drug-approval/BLA125462","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60492-0075"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-03T05:12:36.034Z"}}